90 related articles for article (PubMed ID: 24603101)
1. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.
Spaliviero M; Dalbagni G; Bochner BH; Poon BY; Huang H; Al-Ahmadie HA; Donahue TF; Taylor JM; Meeks JJ; Sjoberg DD; Donat SM; Reuter VE; Herr HW
J Urol; 2014 Sep; 192(3):702-7. PubMed ID: 24603101
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology.
Lone Z; Benidir T; Wood A; Campbell RA; Alaghehbandan R; Li J; Haber GP; Eltemamy M; Haywood SC; Weight CJ; Lee BH; Almassi N
Urol Oncol; 2024 Mar; 42(3):71.e1-71.e7. PubMed ID: 38135626
[TBL] [Abstract][Full Text] [Related]
3. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
Contieri R; Tan WS; Grajales V; Hensley PJ; Martini A; Bree K; Myers A; Nogueras-Gonzalez G; Navai N; Dinney CP; Guo C; Kamat AM
BJU Int; 2024 Jun; 133(6):733-741. PubMed ID: 38374533
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
Scott SN; Ostrovnaya I; Lin CM; Bouvier N; Bochner BH; Iyer G; Solit D; Berger MF; Lin O
Cancer Cytopathol; 2017 Jun; 125(6):416-426. PubMed ID: 28339163
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer.
Koehne EL; Bakaloudi DR; Ghali F; Nyame Y; Schade GR; Grivas P; Yezefski TA; Hawley JE; Yu EY; Hsieh AC; Montgomery RB; Psutka SP; Gore JL; Wright JL
Clin Genitourin Cancer; 2024 Jun; 22(3):102100. PubMed ID: 38763862
[TBL] [Abstract][Full Text] [Related]
6. Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score.
Suartz CV; Cordeiro MD; Botelho LAA; Gallucci FP; Cho DH; de Arruda Pessoa F; da Silva FR; Costa MSS; Cardili L; Audenet F; Mota JM; Toren P; Nahas WC; Ribeiro-Filho LA
World J Urol; 2024 Mar; 42(1):155. PubMed ID: 38483580
[TBL] [Abstract][Full Text] [Related]
7. Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
HacihasanoĞlu E; YÜcetaŞ U; OkÇu O; BehzatoĞlu K
Turk Patoloji Derg; 2021; 37(1):26-31. PubMed ID: 32692402
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases.
Xu VE; Antar RM; Bertozzi L; Drouaud A; Azari S; Lee SM; Whalen MJ
Urol Oncol; 2024 May; 42(5):162.e11-162.e23. PubMed ID: 38480078
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder.
Mally AD; Tin AL; Lee JK; Satasivam P; Cha EK; Donat SM; Herr HW; Bochner BH; Sjoberg DD; Dalbagni G
Clin Genitourin Cancer; 2017 Jul; ():. PubMed ID: 28802887
[TBL] [Abstract][Full Text] [Related]
10. Invasive Micropapillary Urothelial Carcinoma: an Uncommon and Underreported Variant in Cystectomy Specimens.
Prasad P; Baranwal H; Agrawal V
Indian J Surg Oncol; 2023 Mar; 14(1):222-227. PubMed ID: 36891448
[TBL] [Abstract][Full Text] [Related]
11. Oncologic Outcomes of cT1 and cT2 Micropapillary Variant Compared with cT1 and cT2 Conventional Urothelial Carcinoma Treated with Radical Cystectomy.
Ginsburg KB; Schober JP; Bukavina L; Murray N; Chandra AA; Chen DYT; Greenberg RE; Viterbo R; Uzzo RG; Smaldone MC; Kutikov A; Correa AF
Urol Pract; 2022 Sep; 9(5):396-404. PubMed ID: 37145732
[TBL] [Abstract][Full Text] [Related]
12. Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
Montorsi F; Rosiello G; Gandaglia G
Eur Urol Oncol; 2024 Apr; 7(2):300. PubMed ID: 37838554
[No Abstract] [Full Text] [Related]
13. Efficacy of pembrolizumab in a rare type of bladder cancer arising 25 years after augmentation cystoplasty.
Kitamura K; Isotani S; Muto S; Horie S
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354571
[TBL] [Abstract][Full Text] [Related]
14. Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer.
Herzberg H; Ventura Y; Lifshitz K; Savin Z; Golan S; Baniel J; Yossepowitch O; Mano R
Urol Oncol; 2024 Aug; 42(8):246.e7-246.e13. PubMed ID: 38641474
[TBL] [Abstract][Full Text] [Related]
15. Impact of Chart-Derived Frailty Index on 1-Year Mortality After Radical Cystectomy in 1004 Patients with Bladder Cancer.
Yu J; Lee J; Ha S; Baek JW; Kim CS; Park JY; Kim YK
Ann Surg Oncol; 2023 Aug; 30(8):5295-5303. PubMed ID: 37160804
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
Ślusarczyk A
Ann Surg Oncol; 2024 Jun; 31(6):3910-3911. PubMed ID: 38602577
[No Abstract] [Full Text] [Related]
17. Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes.
Burge F; Kockelbergh R
Urol Int; 2016; 97(4):373-379. PubMed ID: 27595416
[TBL] [Abstract][Full Text] [Related]
18. Patient experience of surveillance following radical treatment for muscle-invasive bladder cancer.
Hack J; Douglas J; Makaroff L; Costin M; Kelly P; Knight A; Chamberlain S; Crabb S
BJU Int; 2024 Apr; 133(4):410-412. PubMed ID: 38093704
[No Abstract] [Full Text] [Related]
19. Active surveillance for micropapillary thyroid carcinoma: a clinical review.
Shaha AR; Tuttle RM
Gland Surg; 2024 Jan; 13(1):100-107. PubMed ID: 38323232
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of cT1 micropapillary bladder cancer.
Willis DL; Fernandez MI; Dickstein RJ; Parikh S; Shah JB; Pisters LL; Guo CC; Henderson S; Czerniak BA; Grossman HB; Dinney CP; Kamat AM
J Urol; 2015 Apr; 193(4):1129-34. PubMed ID: 25254936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
